Effect of Costimulatory Blockade with Abatacept after Ustekinumab Withdrawal in Patients with Moderate to Severe Plaque Psoriasis: The PAUSE Randomized Clinical Trial

Kristina M. Harris*, Dawn E. Smilek, Margie Byron, Noha Lim, William T. Barry, James McNamara, Sandra Garcet, Robert J. Konrad, Martin Stengelin, Pradeepthi Bathala, Neil J. Korman, Steven R. Feldman, Erin E. Boh, Kirk Barber, Anne E. Laumann, Yolanda Rosi Helfrich, Gerald G. Krueger, Howard Sofen, Robert Bissonnette, James G. Krueger

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Effect of Costimulatory Blockade with Abatacept after Ustekinumab Withdrawal in Patients with Moderate to Severe Plaque Psoriasis: The PAUSE Randomized Clinical Trial'. Together they form a unique fingerprint.

Nursing and Health Professions

Immunology and Microbiology

INIS